IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Delisted

IDXG was delisted on the 24th of February, 2021.

Back to rankings

3 hedge funds and large institutions have $58K invested in Interpace Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$52K
2
+$5K

Top Sellers

1
-$368K
2
-$253K
3
-$101K
4
Squarepoint
Squarepoint
New York
-$65K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
1
HRT Financial
New York
$52K
RG
2
Retirement Group
California
$5K
TRCT
3
Tower Research Capital (TRC)
New York
$1K
BlackRock
4
BlackRock
New York
–
Vanguard Group
5
Vanguard Group
Pennsylvania
–
Geode Capital Management
6
Geode Capital Management
Massachusetts
–
Squarepoint
7
Squarepoint
New York
–
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
–
UBS Group
9
UBS Group
Switzerland
–
AF
10
Allworth Financial
California
–
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
–